Clinical Trial Update: Remifentanil Infusion Alone During the Closure Period for Early Emergence Following Craniotomy [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating remifentanil infusion during the closure period after craniotomy to promote early emergence in patients with supratentorial brain neopl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasms

Drugs mentioned

• Remifentanil (remifentanil)

Snippet

Sponsor: Yeditepe University Hospital | Conditions: Supratentorial Neoplasms | Phase 4 | Status: COMPLETED